# Study to Assess the Effect of Branebrutinib on the Drug Levels of Rosuvastatin in Healthy Participants

> **NCT04515628** · PHASE1 · COMPLETED · sponsor: **Bristol-Myers Squibb** · enrollment: 22 (actual)

## Conditions studied

- Healthy Participants

## Interventions

- **DRUG:** Rosuvastatin
- **DRUG:** Branebrutinib

## Key facts

- **NCT ID:** NCT04515628
- **Lead sponsor:** Bristol-Myers Squibb
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-08-02
- **Primary completion:** 2020-10-18
- **Final completion:** 2020-10-26
- **Target enrollment:** 22 (ACTUAL)
- **Last updated:** 2022-03-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04515628

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04515628, "Study to Assess the Effect of Branebrutinib on the Drug Levels of Rosuvastatin in Healthy Participants". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT04515628. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*